Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$145.48 - $167.38 $18.4 Million - $21.2 Million
126,556 Added 70.14%
307,000 $49.8 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $19.5 Million - $21.3 Million
135,300 Added 299.71%
180,444 $26.4 Million
Q1 2024

May 14, 2024

BUY
$155.22 - $162.74 $2.18 Million - $2.29 Million
14,044 Added 45.16%
45,144 $7.14 Million
Q4 2023

Feb 13, 2024

BUY
$145.6 - $158.88 $4.53 Million - $4.94 Million
31,100 New
31,100 $4.87 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.